Current Psychotherapeutic Drugs

Current Psychotherapeutic Drugs
Author: Frederic M. Quitkin
Publisher: American Psychiatric Pub
Total Pages: 202
Release: 1998
Genre: Medical
ISBN: 9780880489942

A compendium of the major classes of drugs, this invaluable, clinical guide to the pharmacology of psychiatric disorders includes graphs and tables illustrating drug effects and treatment results. Each drug is given a brief description-including controversies, side-effects, and uses-and is listed in alphabetical order within six major categories authorized by recognized experts in their fields: * Stimulants, Arthur Rifkin, M.D.* Antidepressants, Frederic M. Quitkin, M.D., Bonnie P. Taylor, M.A.* Antimanic Agents, Charles L. Bowden, M.D.* Sedative-Hypnotics, Eric J. Heyer, M.D., Ph.D., David C. Adams, M.D.* Antipsychotic Agents, Rajiv Tandon, M.D.* Antianxiety Agents: Benzodiazepine Derivatives, Edward M. Sellers, M.D., Ph. D., F.R.C.P.C.

Current Psychotherapeutic Drugs

Current Psychotherapeutic Drugs
Author: Donald F. Klein
Publisher: Routledge
Total Pages: 183
Release: 2013-05-24
Genre: Psychology
ISBN: 1135062854

Published in 1996, Current Psychotherapeutic Drugs is a valuable contribution to the field of Psychotherapy.

What Is Psychotherapy?

What Is Psychotherapy?
Author: The School of Life
Publisher: School of Life
Total Pages: 120
Release: 2018
Genre: Psychotherapy
ISBN: 9781999747176

An in-depth look at a much misunderstood practice, offering a fresh viewpoint on how this science can be a universally effective route to our better selves.

Harm Reduction Psychotherapy

Harm Reduction Psychotherapy
Author: Andrew Tatarsky
Publisher: Jason Aronson
Total Pages: 392
Release: 2007-06-10
Genre: Psychology
ISBN: 1461628709

This ground-breaking volume provides readers with both an overview of harm reduction therapy and a series of ten case studies, treated by different therapists, that vividly illustrate this treatment approach with a wide variety of clients. Harm reduction is a framework for helping drug and alcohol users who cannot or will not stop completely—the majority of users—reduce the harmful consequences of use. Harm reduction accepts that abstinence may be the best outcome for many but relaxes the emphasis on abstinence as the only acceptable goal and criterion of success. Instead, smaller incremental changes in the direction of reduced harmfulness of drug use are accepted. This book will show how these simple changes in emphasis and expectation have dramatic implications for improving the effectiveness of psychotherapy in many ways. From the Foreword by Alan Marlatt, Ph.D.: “This ground-breaking volume provides readers with both an overview of harm reduction therapy and a series of ten case studies, treated by different therapists, that vividly illustrate this treatment approach with a wide variety of clients. In his introduction, Andrew Tatarsky describes harm reduction as a new paradigm for treating drug and alcohol problems. Some would say that harm reduction embraces a paradigm shift in addiction treatment, as it has moved the field beyond the traditional abstinence-only focus typically associated with the disease model and the ideology of the twelve-step approach. Others may conclude that the move toward harm reduction represents an integration of what Dr. Tatarsky describes as the “basic principles of good clinical practice” into the treatment of addictive behaviors. “Changing addiction behavior is often a complex and complicated process for both client and therapist. What seems to work best is the development of a strong therapeutic alliance, the right fit between the client and treatment provider. The role of the harm reduction therapist is closer to that of a guide, someone who can provide support an

Psychotherapy for the Treatment of Substance Abuse

Psychotherapy for the Treatment of Substance Abuse
Author: Marc Galanter
Publisher: American Psychiatric Pub
Total Pages: 430
Release: 2011
Genre: Medical
ISBN: 1585623903

In Psychotherapy for the Treatment of Substance Abuse, leading authorities on substance abuse treatment techniques review and illustrate the most common interventions for opioid-related and alcohol-related substance abuse disorders, as well as crucial methodologies for testing and patient placement. Methods reviewed include self-help fellowships such as Alcoholics Anonymous, cognitive-behavioral and psychodynamic treatments, motivational enhancement, group and family therapy, contingency management, and the multimodal approach called Network Therapy, which recruits the support of friends and family to prompt abstinence and prevent relapse. Each chapter includes vivid case studies to illustrate the approach described, as well as a review of the key clinical concepts and a list of essential readings. Adapting a new, clinically focused manual from their popular American Psychiatric Publishing Textbook of Substance Abuse Treatment, now in its fourth edition, Dr. Galanter and Dr. Kleber have designed Psychotherapy for the Treatment of Substance Abuse to be of practical application to both experienced clinicians and those new to the field. The accompanying DVD demonstrates Network Therapy in practice and includes enlightening commentary on key issues that are relevant across the many modalities of substance abuse treatment discussed in the book.

Pharmacological Treatment of Mental Disorders in Primary Health Care

Pharmacological Treatment of Mental Disorders in Primary Health Care
Author: World Health Organization
Publisher: World Health Organization
Total Pages: 80
Release: 2009
Genre: Medical
ISBN: 9241547693

This manual attempts to provide simple, adequate and evidence-based information to health care professionals in primary health care especially in low- and middle-income countries to be able to provide pharmacological treatment to persons with mental disorders. The manual contains basic principles of prescribing followed by chapters on medicines used in psychotic disorders; depressive disorders; bipolar disorders; generalized anxiety and sleep disorders; obsessive compulsive disorders and panic attacks; and alcohol and opioid dependence. The annexes provide information on evidence retrieval, assessment and synthesis and the peer view process.

Managing Treatment-Resistant Depression

Managing Treatment-Resistant Depression
Author: Joao Luciano de Quevedo
Publisher: Elsevier
Total Pages: 612
Release: 2022-04-04
Genre: Medical
ISBN: 0128240679

Managing Treatment-Resistant Depression: Road to Novel Therapeutics defines TRD for readers, discussing the clinical and epidemiological predictors, economic burden and neurobiological factors. In addition, staging methods for treatment resistance are fully covered in this book, including serotonin specific reuptake inhibitors, serotonin norepinephrine reuptake inhibitors, other classes of antidepressants, including tricyclic antidepressants and monoamine oxidase inhibitors, augmentation strategies, and newer antidepressant treatments like ketamine and esketamine. In addition, evidence supporting the use of psychotherapies and neuromodulation strategies are also reviewed. Written by top experts in the field, this book is the first of its kind to review all methods of treatment for TRD. Defines Treatment-Resistant Depression and Staging Treatment Intensity Includes Treatment-Resistant Depression options for children, adolescents, geriatrics, during pregnancy, and during post-partum and menopause transitions Discusses the use of Ketamine and Esketamine for treatment-resistant depression

Integrating Psychotherapy and Psychopharmacology

Integrating Psychotherapy and Psychopharmacology
Author: Irismar Reis de Oliveira
Publisher: Routledge
Total Pages: 465
Release: 2013-12-04
Genre: Psychology
ISBN: 1136302816

Integrating Psychotherapy and Psychopharmacology: A Handbook for Clinicians is a practical guide for the growing number of mental-health practitioners searching for information on treatments that combine psychopharmacology, psychotherapy, and psychosocial rehabilitation. Research shows that combined approaches are among the most effective ways to treat an increasing number of psychiatric disorders. However, though these combined treatments are becoming the everyday practice of psychiatrists, psychologists, and other mental-health professionals, identifying the right treatment plan can be notoriously difficult, and clinicians are often left scrambling to answer questions about how to design and customize their treatment strategies. In Integrating Psychotherapy and Psychopharmacology, readers will find these questions fully addressed and the answers explained, and they’ll come away from the book with a toolbox full of strategies for helping their patients improve symptoms, achieve remission, and stay well using a combination of drug and psychological treatments.